Forty-four MCAS patients had additional associated hematologic neoplasms, most frequently multiple myeloma, JAK2-positive essential thrombocytosis, and chronic lymphocytic leukemia (Table 2). Here, JAK2 is linked to B-cell chronic lymphocytic leukemia.